{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:43:38Z","timestamp":1794339818811,"version":"4.9.0"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Preclinical studies have indicated that Angong Niuhuang Pills (ANP) reduce cerebral infarct and edema volumes. This study aimed to investigate whether ANP safely reduces cerebral infarct and edema volumes in patients with moderate to severe acute ischemic stroke.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This randomized, double-blind, placebo-controlled pilot trial included patients with acute ischemic stroke with National Institutes of Health Stroke Scale (NIHSS) scores ranging from 10 to 20 in 17 centers in China between April 2021 and July 2022. Patients were allocated within 36 h after onset via block randomization to receive ANP or placebo (3 g\/day for 5 days). The primary outcomes were changes in cerebral infarct and edema volumes after 14 days of treatment. The primary safety outcome was severe adverse events (SAEs) for 90 days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were 57 and 60 patients finally included in the ANP and placebo groups, respectively for modified intention-to-treat analysis. The median age was 66.0 years, and the median NIHSS score at baseline was 12.0. The changes in cerebral infarct volume at day 14 were 0.3 mL and 0.4 mL in the ANP and placebo groups, respectively (median difference: \u20137.1 mL; interquartile range [IQR]: \u221218.3 to 2.3 mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.30). The changes in cerebral edema volume of the ANP and placebo groups on day 14 were 11.4 mL and 4.0 mL, respectively (\n                      <jats:italic toggle=\"yes\">median difference: 3.0 mL, IQR: \u22121.3 to 9.9 mL, P<\/jats:italic>\n                      = 0.15). The rates of SAE within 90 days were similar in the ANP (3\/57, 5%) and placebo (7\/60, 12%) groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.36). Changes in serum mercury and arsenic concentrations were comparable. In patients with large artery atherosclerosis, ANP reduced the cerebral infarct volume at 14 days (median difference: \u201312.3 mL; IQR: \u201327.7 to \u20130.3 mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>ANP showed a similar safety profile to placebo and non-significant tendency to reduce cerebral infarct volume in patients with moderate-to-severe stroke. Further studies are warranted to assess the efficacy of ANP in reducing cerebral infarcts and improving clinical prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trail Registration:<\/jats:title>\n                    <jats:p>Clinicaltrials.gov, No. NCT04475328.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003133","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T04:11:50Z","timestamp":1730866310000},"page":"579-588","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Safety and efficacy of Angong Niuhuang Pills in patients with moderate-to-severe acute ischemic stroke (ANGONG TRIAL): A randomized double-blind placebo-controlled pilot clinical trial"],"prefix":"10.1097","volume":"138","author":[{"given":"Shengde","family":"Li","sequence":"first","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Shi","sequence":"additional","affiliation":[{"name":"BrainNow Research Institute, Shenzhen, Guangdong 518000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second People\u2019s Hospital of Yibin, Yibin, Sichuan 644000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Anhui University of Technology, Huainan, Anhui 232007, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Brain Hospital of Hunan Province (The Second People\u2019s Hospital of Hunan Province), Changsha, Hunan 410007, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hengshui People\u2019s Hospital, Hengshui, Hebei 053000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First People\u2019s Hospital of Yibin, Yibin, Sichuan 644000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First People\u2019s Hospital of Changde City, Changde, Hunan 415000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First People\u2019s Hospital of Zhangjiagang City, Suzhou, Jiangsu 215600, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingcheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The People\u2019s Hospital of Anyang City, Anyang, Henan 455000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianbo","family":"Zhuang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Liaocheng People\u2019s Hospital, Liaocheng, Shandong 252000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"You","sequence":"additional","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Radiology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishan","family":"Luo","sequence":"additional","affiliation":[{"name":"BrainNow Research Institute, Shenzhen, Guangdong 518000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Occupational Medicine and Toxicologym, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ni","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"R1-20250828","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/STROKEAHA.111.639401","article-title":"Infarct volume is a pivotal biomarker after intra-arterial stroke therapy","volume":"43","author":"Yoo","year":"2012","journal-title":"Stroke"},{"key":"R2-20250828","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/STROKEAHA.118.020788","article-title":"Quantifying infarct growth and secondary injury volumes: Comparing multimodal image registration measures","volume":"49","author":"Harston","year":"2018","journal-title":"Stroke"},{"key":"R3-20250828","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJMoa2214403","article-title":"Trial of endovascular thrombectomy for large ischemic strokes","volume":"388","author":"Sarraj","year":"2023","journal-title":"N Engl J Med"},{"key":"R4-20250828","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"R5-20250828","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"R6-20250828","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"Nogueira","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20250828","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jns.2014.09.048","article-title":"Early infarct growth predicts long-term clinical outcome in ischemic stroke","volume":"347","author":"Kim","year":"2014","journal-title":"J Neurol Sci"},{"key":"R8-20250828","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/STROKEAHA.119.025809","article-title":"Clinical and imaging parameters associated with hyperacute infarction growth in large vessel occlusion stroke","volume":"50","author":"Puhr-Westerheide","year":"2019","journal-title":"Stroke"},{"key":"R9-20250828","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.2016.13647","article-title":"Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: A meta-analysis","volume":"316","author":"Saver","year":"2016","journal-title":"JAMA"},{"key":"R10-20250828","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0140-6736(14)60584-5","article-title":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials","volume":"384","author":"Emberson","year":"2014","journal-title":"Lancet"},{"key":"R11-20250828","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJMoa1813046","article-title":"Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke","volume":"380","author":"Ma","year":"2019","journal-title":"N Engl J Med"},{"key":"R12-20250828","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5853\/jos.2016.01515","article-title":"Strategies to extend thrombolytic time window for ischemic stroke treatment: An unmet clinical need","volume":"19","author":"Pe\u00f1a","year":"2017","journal-title":"J Stroke"},{"key":"R13-20250828","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/1747493019851278","article-title":"Factors influencing infarct growth including collateral status assessed using computed tomography in acute stroke patients with large artery occlusion","volume":"14","author":"Jiang","year":"2019","journal-title":"Int J Stroke"},{"key":"R14-20250828","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/STROKEAHA.122.039090","article-title":"Early and delayed infarct growth in patients undergoing mechanical thrombectomy: A prospective, serial MRI study","volume":"54","author":"Hern\u00e1ndez-P\u00e9rez","year":"2023","journal-title":"Stroke"},{"key":"R15-20250828","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3174\/ajnr.A7177","article-title":"Infarct growth despite successful endovascular reperfusion in acute ischemic stroke: A meta-analysis","volume":"42","author":"Bala","year":"2021","journal-title":"AJNR Am J Neuroradiol"},{"key":"R16-20250828","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000448329","article-title":"Post stroke dysglycemia and acute infarct volume growth: A study using continuous glucose monitoring","volume":"76","author":"Shimoyama","year":"2016","journal-title":"Eur Neurol"},{"key":"R17-20250828","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1177\/0271678X17720559","article-title":"Reperfusion after ischemic stroke is associated with reduced brain edema","volume":"38","author":"Irvine","year":"2018","journal-title":"J Cereb Blood Flow Metab"},{"key":"R18-20250828","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1161\/STROKEAHA.114.006884","article-title":"Brain edema predicts outcome after nonlacunar ischemic stroke","volume":"45","author":"Battey","year":"2014","journal-title":"Stroke"},{"key":"R19-20250828","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1097\/CM9.0000000000002885","article-title":"Definition, prediction, prevention and management of patients with severe ischemic stroke and large infarction","volume":"136","author":"Hua","year":"2023","journal-title":"Chin Med J"},{"key":"R20-20250828","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1474-4422(07)70036-4","article-title":"Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials","volume":"6","author":"Vahedi","year":"2007","journal-title":"Lancet Neurol"},{"key":"R21-20250828","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12028-015-0144-7","article-title":"Complications associated with decompressive craniectomy: A systematic review","volume":"23","author":"Kurland","year":"2015","journal-title":"Neurocrit Care"},{"key":"R22-20250828","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","article-title":"Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): A randomised, double-blind, placebo-controlled phase 2 trial","volume":"15","author":"Sheth","year":"2016","journal-title":"Lancet Neurol"},{"key":"R23-20250828","doi-asserted-by":"crossref","first-page":"346918","DOI":"10.1155\/2014\/346918","article-title":"Use of Angong Niuhuang in treating central nervous system diseases and related research","volume":"2014","author":"Guo","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"R24-20250828","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jep.2016.11.015","article-title":"Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis","volume":"195","author":"Fu","year":"2017","journal-title":"J Ethnopharmacol"},{"key":"R25-20250828","doi-asserted-by":"crossref","first-page":"1001422","DOI":"10.3389\/fphar.2022.1001422","article-title":"Angong Niuhuang Pill ameliorates cerebral ischemia\/reperfusion injury in mice partly by restoring gut microbiota dysbiosis","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Pharmacol"},{"key":"R26-20250828","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jep.2019.03.043","article-title":"Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage: A meta-analysis of randomized controlled trials","volume":"237","author":"Liu","year":"2019","journal-title":"J Ethnopharmacol"},{"key":"R27-20250828","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12011-015-0318-3","article-title":"Whether metal element-containing herbal formula Angong Niuhuang Pill is safe for acute brain disorders?","volume":"166","author":"Zhao","year":"2015","journal-title":"Biol Trace Elem Res"},{"key":"R28-20250828","first-page":"666","article-title":"Chinese guidelines for diagnosis and treatment of acute ischemic stroke 2018","volume":"51","year":"2018","journal-title":"Chin J Neurol"},{"key":"R29-20250828","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12880-022-00841-2","article-title":"Automated brain volumetric measures with AccuBrain: Version comparison in accuracy, reproducibility and application for diagnosis","volume":"22","author":"Zhao","year":"2022","journal-title":"BMC Med Imaging"},{"key":"R30-20250828","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1161\/STROKEAHA.112.671594","article-title":"Final infarct volume is a stronger predictor of outcome than recanalization in patients with proximal middle cerebral artery occlusion treated with endovascular therapy","volume":"43","author":"Zaidi","year":"2012","journal-title":"Stroke"},{"key":"R31-20250828","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00415-021-10410-2","article-title":"Relationship between the degree of recanalization and functional outcome in acute ischemic stroke is mediated by penumbra salvage volume","volume":"268","author":"Broocks","year":"2021","journal-title":"J Neurol"},{"key":"R32-20250828","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jon.12796","article-title":"Infarct growth despite endovascular thrombectomy recanalization in large vessel occlusive stroke","volume":"31","author":"Regenhardt","year":"2021","journal-title":"J Neuroimaging"},{"key":"R33-20250828","doi-asserted-by":"crossref","first-page":"977608","DOI":"10.3389\/fneur.2022.977608","article-title":"Risk factors of late lesion growth after acute ischemic stroke treatment","volume":"13","author":"Konduri","year":"2022","journal-title":"Front Neurol"},{"key":"R34-20250828","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/01.str.0000441965.15164.d6","article-title":"Recommendations for the management of cerebral and cerebellar infarction with swelling: A statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"45","author":"Wijdicks","year":"2014","journal-title":"Stroke"},{"key":"R35-20250828","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1161\/STROKEAHA.120.033246","article-title":"Cerebral edema in patients with large hemispheric infarct undergoing reperfusion treatment: A HERMES meta-analysis","volume":"52","author":"Ng","year":"2021","journal-title":"Stroke"},{"issue":"24 Pt 2","key":"R36-20250828","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1212\/01.wnl.0000304346.14354.0b","article-title":"Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes","volume":"70","author":"Sato","year":"2008","journal-title":"Neurology"},{"key":"R37-20250828","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.jvs.2018.07.079","article-title":"Patients with moderate to severe strokes (NIHSS score >10) undergoing urgent carotid interventions within 48 hours have worse functional outcomes","volume":"69","author":"Mihindu","year":"2019","journal-title":"J Vasc Surg"},{"key":"R38-20250828","doi-asserted-by":"crossref","first-page":"e2292","DOI":"10.1212\/WNL.0000000000012943","article-title":"Acute ischemic stroke interventions in the United States and racial, socioeconomic, and geographic disparities","volume":"97","author":"de Havenon","year":"2021","journal-title":"Neurology"},{"key":"R39-20250828","doi-asserted-by":"crossref","first-page":"114613","DOI":"10.1016\/j.taap.2019.114613","article-title":"Realgar and cinnabar are essential components contributing to neuroprotection of Angong Niuhuang Wan with no hepatorenal toxicity in transient ischemic brain injury","volume":"377","author":"Tsoi","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"R40-20250828","doi-asserted-by":"crossref","first-page":"26","DOI":"10.31083\/j.jin2101026","article-title":"Traditional medicine in China for ischemic stroke: Bioactive components, pharmacology, and mechanisms","volume":"21","author":"Xu","year":"2022","journal-title":"J Integr Neurosci"},{"key":"R41-20250828","first-page":"650","article-title":"Effectiveness and safety of Angong Niuhuang Pill in treatment of acute stroke: A systematic review and Meta-analysis","volume":"43","author":"Xiangran","year":"2023","journal-title":"J Tradit Chin Med"},{"key":"R42-20250828","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/jon.12423","article-title":"The association between diffusion MRI-defined infarct volume and NIHSS score in patients with minor acute stroke","volume":"27","author":"Yaghi","year":"2017","journal-title":"J Neuroimaging"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003133","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T15:01:09Z","timestamp":1756393269000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003133","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,6]]},"assertion":[{"value":"2024-05-05","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}